New findings confirm that regression of liver fibrosis after sustained virologic response is possible after direct-acting antiviral drug therapy for chronic hepatitis C virus infection, but recovery might take almost twice as long as predicted by transient elastography assessment.
A group of researchers, who presented their findings at the 2017 International Liver Congress, regularly used TE to monitor a group of 100 patients after SVR for up to seven years (abstract LBP-530). Later, they